[ Price : $8.95]
FDA grants Catabasis Pharmaceuticals an orphan drug designation for CAT-1004 for treating Duchenne muscular dystrophy.[ Price : $8.95]
FDA issues three additional guidance documents to assist firms that compound sterile human drugs with registering as outsourcing f...[ Price : $8.95]
Comments on FDAs social media promotions guidance urge the agency to allow direct links to side effect information.[ Price : $8.95]
Federal Register Notice: FDA seeks comments on recordkeeping for animal food/feed prohibited substances.[ Price : $8.95]
Federal Register Notice: FDA releases a guidance: Changes to an Approved Application: Biological Products: Human Blood and Blood C...[ Price : $8.95]
Federal Register Notice: FDA corrects the name of an organization a 9/23 notice on report on the standardization of risk evaluatio...[ Price : $8.95]
Federal Register Notice: FDA plans a public workshop 12/12 on developing therapies in the omics era and using rare subsets of pati...[ Price : $8.95]
Federal Register Notice: FDAs Anti-Infective Drugs Advisory Committee will meet 1/22/15 to discuss Astellas Pharma NDAs for treati...